Clinical Trial Update: Expanded Access Program for Olaparib Tablets as Maintenance Therapy in Patients With Ovarian, Fallopian Tube or Primary Peritoneal Cancer.

View source ↗

Summary

Update notes that Olaparib is available via an expanded access program as maintenance therapy for ovarian, fallopian tube, or primary peritoneal cancer, with th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Lynparza (olaparib)

Snippet

Sponsor: AstraZeneca | Conditions: Ovarian Cancer | Status: APPROVED_FOR_MARKETING